Purpose: Kidney stone disease has become increasingly common during childhood and adolescence. However, the rate of symptomatic kidney stone recurrence for pediatric patients is uncertain. We sought to determine the recurrence rate of symptomatic kidney stones in a cohort of children with incident symptomatic nephrolithiasis. Materials and Methods: We performed a retrospective cohort study of patients 3 to 18 years old without anatomical abnormalities or genetic causes of nephrolithiasis who presented with a first symptomatic kidney stone between 2008 and 2014. We determined recurrence rates of symptomatic nephrolithiasis, defined as a new kidney stone on ultrasound and/or computerized tomogram associated with pain and/or vomiting. We also estimated associations between completing 24-hour urinalysis and symptomatic kidney stone recurrence using Kaplan-Meier curves and multivariable Cox regression models. Results: A total of 285 children with a median age of 14.8 years (IQR 11.3e16.6) at nephrolithiasis diagnosis were followed for 492 person-years. A total of 86 symptomatic recurrent stones developed in 68 patients (24%) during the followup period. The probability of symptomatic stone recurrence was 50% at 3 years after the index kidney stone. Median time to stone recurrence was 3 years at the first recurrence and 5 years at the second. Adjusting for confounders including adherence to followup, completing a 24-hour urinalysis after a kidney stone episode was associated with a 60% decreased risk of recurrence (hazard ratio 0.40, 95% CI 0.18e0.91). Conclusions: The risk of kidney stone recurrence is high during childhood, with approximately 50% of children presenting with symptomatic recurrence within 3 years of the first stone. The role and usefulness of analyzing 24-hour urine chemistries in decreasing kidney stone recurrence should be explored in future prospective studies.
NEPHROLITHIASIS is a systemic disorder characterized by symptomatic recurrence that is associated with an increased risk of cardiovascular disease 1 and chronic kidney disease in adults, 2 and fracture in children and adults. 3 The incidence of nephrolithiasis in children and adolescents has increased rapidly in the last 25 years, producing a new population of pediatric patients at risk for kidney stone recurrence. 4e7 Approximately 50% of adults with incident nephrolithiasis will demonstrate a The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
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There is also a lack of consensus regarding recommended evaluation and treatment practices to decrease kidney stone recurrence in children. The European Association of Urology recommends analyzing 24-hour urine collections for high risk patients to assess metabolic risk and target therapy to decrease recurrence. 9 The American Urological Association guidelines do not specifically address pediatric patients. 10 The American College of Physicians does not endorse performing 24-hour urine collections as the panel has deemed there is insufficient evidence that assessing urine chemistry before initiating PPT or dietary interventions reduces stone recurrence. 11 We determined the recurrence rate of symptomatic kidney stones in a cohort of children with incident symptomatic nephrolithiasis. We also evaluated the association between performance of 24-hour urinalysis and kidney stone recurrence. We hypothesized that completion of 24-hour urinalysis is associated with a decreased risk of recurrence.
MATERIALS AND METHODS

Study Design and Patient Population
We performed a retrospective cohort study of patients 3 to 18 years old who presented with a first symptomatic kidney stone, defined as abdominal or flank pain and/or nausea/vomiting with a kidney stone on ultrasound and/ or computerized tomogram between January 1, 2008 and April 1, 2014. All patients were treated at our institution and were identified by searching the outpatient and hospital billing databases for International Classification of Diseases, 9th edition codes for nephrolithiasis (592.0, 592.1, 592.9, 274.11). Electronic medical records were reviewed and data were entered into Research Electronic Data Capture hosted at CHOP using standardized abstraction forms. 12 The study was approved by the local institutional review board.
The goal of this study was to define the risk of symptomatic stone recurrence for the typical child with an incident symptomatic kidney stone. To do this, we had to balance including children with diseases that are associated with nephrolithiasis but exclude those children with diseases who would likely have drastically different recurrence rates than other patients. Thus, we included patients with cystic fibrosis, inflammatory bowel disease, diabetes, nephrocalcinosis, renal dysplasia and hypertension. We excluded patients with myelomeningocele, monogenic causes of nephrolithiasis (cystinuria, HPRT mutations, primary xanthinuria and primary hyperoxaluria), renal tubular acidosis and inborn errors of metabolism. We also excluded patients who had not achieved continence, those with diseases that produce stone symptoms (eg ureteropelvic junction obstruction) and those with asymptomatic stones to eliminate lead time bias introduced by more frequent imaging in some patients.
All patients were treated and followed at the pediatric kidney stone center at CHOP using our clinical care pathway for children with nephrolithiasis. 13 The care pathway includes ordering 24-hour urinalyses every 6 months beginning at the initial stone event regardless of the perceived risk of recurrence and providing all patients with dietary counseling.
Outcome
The primary outcome was symptomatic kidney stone recurrence, defined as pain and/or vomiting with a new stone on ultrasound and/or computerized tomogram. We used strict criteria to define kidney stone clearance to determine which patients were "eligible" for stone recurrence. Kidney stone clearance was defined as resolution of symptoms with clearance of the offending stone on imaging following ureteroscopy, shock wave lithotripsy, percutaneous nephrolithotomy or spontaneous stone passage. Because residual symptoms may occur following surgery or stone passage, a minimum of 30 days was required after stone clearance before a patient could be eligible for recurrence. A kidney stone episode was the time between presentation and recurrence after clearance of the initial stone, or between initial presentation and last followup for those without recurrence. Patients were censored at last followup in urology, nephrology or primary care, transfer to adult care or death.
Exposures
Completion of 24-hour urinalysis and prescription of PPT were the primary exposures. We assessed initiation and discontinuation of PPT by reviewing the clinical documentation and electronic medication list at each encounter. The values used to define abnormalities on 24-hour urinalyses were hypercalciuria (greater than 4 mg/kg), hypocitraturia (less than 130 mg/gm creatinine for boys and less than 300 mg/gm for girls), hyperoxaluria (greater than 40 mg/1.73 m 2 ) and low urine volume (less than 1 cc/kg per hour for 24 hours).
Statistical Analysis
Kaplan-Meier curves were used to estimate unadjusted recurrence rates for the overall population and cohorts were stratified by completion of 24-hour urinalysis. Multivariable Cox proportional hazard regression using conditional risk set models was used to estimate the association between completion of 24-hour urinalysis, PPT prescription and stone recurrence. 14 We used these models because kidney stones can recur multiple times for each individual and recurrences may be correlated within individual patients.
The first model estimated the association between completion of at least one 24-hour urinalysis after a stone episode and stone recurrence. The second model included an interaction term between completion of a 24-hour urinalysis and initiation of PPT to test the a priori hypothesis that assessing urine chemistry before initiating PPT is associated with decreased stone recurrence. The 24-hour urine collections and PPT were considered time varying covariates because they could occur at any time after the index stone. Regression models were built using manual backward selection of covariates. Covariates assessed for inclusion in the models were age at diagnosis (years), age and gender specific BMI percentile, comorbidities (presence or absence of cystic fibrosis, inflammatory bowel disease, diabetes, nephrocalcinosis, renal dysplasia and hypertension), family history of nephrolithiasis, stone analysis, insurance status (commercial vs public/uninsured) and adherence to followup. BMI percentile was determined using Centers for Disease Control and Prevention growth curves. Adherence was a continuous variable defined as proportion of attended outpatient visits divided by total number of scheduled visits (attended plus missed). 15 We included in the final models all covariates with face validity (gender, age, adherence) and those that exhibited significant confounding, defined as 15% or greater change in the hazard ratio for recurrence and completion of 24-hour urine collection (model 1), and interaction between 24-hour urine collection and PPT (model 2). Proportionality of hazards was assessed using KaplanMeier curves for time fixed covariates, and evaluating the interaction between time and each time varying covariate. Sensitivity analyses were performed 1) excluding patients with comorbid diseases listed in our inclusion criteria, and 2) modeling recurrence as time from previous event rather than time from study entry.
At 90% power 74 recurrent stones in patients who did and patients who did not complete 24-hour urine collections would be needed to detect a 45% difference in the hazard rates for stone recurrence, which is the relative risk reduction of stone growth observed in children treated with citrate therapy. 16 Analyses were performed in patients for whom complete data were available using StataÒ, version 13. Tests were 2-sided and p <0.05 was the threshold for statistical significance.
RESULTS
A total of 285 patients were followed for 492 personyears ( fig. 1 and table 1 ). Of the patients 20 (7%) had 32 medical comorbidities, the most common of which were renal dysplasia (7 patients), cystic fibrosis (7), inflammatory bowel disease (5) and either type 1 diabetes or diabetes associated with cystic fibrosis (4) .
Including the index stone, 371 stones occurred, with 68 patients (24%) having 86 symptomatic recurrent stones during the followup period. The probability of recurrence was 50% at 3 years after the index stone ( fig. 2) . Median time to stone recurrence was 3 years for the first recurrence and 5 years for the second. Overall recurrence rate was 197 stones per 1,000 person-years (95% CI 159e243). Of the patients 101 (35%) underwent surgery during the study period. A total of 166 stones were collected at surgery or after spontaneous passage, of which 124 (93%) were at least 50% calcium oxalate, 5 (3%) were pure calcium phosphate, 3 (2%) were uric acid and 1 (1%) was struvite, with the composition being unavailable for the remaining 15 (9%).
A total of 196 patients (69%) completed a 24-hour urinalysis, of whom 20% had hypercalciuria, 15% hypocitraturia and 70% inadequate urine volume on at least one 24-hour urinalysis. When stratified by stone episode, the proportion of children who had adequate urine output as measured on the first urine collection for each stone episode increased from 27% to 44% to 57%. A total of 42 patients (17%) were prescribed PPT, of whom 7 did not complete a 24-hour urine collection (table 2) .
Recurrence rates for patients who did and patients who did not complete a 24-hour urinalysis were 185 and 242 stones per 1,000 person-years, respectively ( fig. 3) . The final Cox models were adjusted for age, gender, BMI percentile, comorbid disease, completion of stone analysis and adherence to followup. In our primary analysis examining the relationship between 24-hour urinalysis and recurrence the completion of 24-hour urinalysis after the stone episode was associated with a 60% lower hazard of stone recurrence (HR 0.40, 95% CI 0.18e0.91). In our secondary analysis examining the interaction between 24-hour urinalysis, PPT and stone recurrence PPT initiated after completion of a 24-hour urinalysis was associated with an 85% decrease in risk of stone recurrence (HR 0.15, 95% CI 0.04e0.57), whereas PPT without a 24-hour urinalysis was not associated with decreased recurrence risk (table 3) .
In sensitivity analyses the associations between completing a 24-hour urinalysis and stone recurrence changed minimally when patients with comorbidities were excluded. In the second model, which included the interaction between 24-hour urinalysis and PPT, the association between completing a 24-hour urinalysis without PPT and stone recurrence became statistically significant (HR 0.40, 95% CI 0.17e0.98). Results were unchanged when recurrence was modeled as time from previous event rather than time from study entry.
DISCUSSION
Among patients who first presented with nephrolithiasis during childhood the probability of symptomatic kidney stone recurrence was approximately 50% within 3 years of the index stone. This rate is similar to or greater than stone recurrence rates for adults. 8 Before this study, knowledge of recurrence rates for patients in whom nephrolithiasis began during childhood was limited. Two prior retrospective cohort series revealed that 16% to 19% of patients who formed stones in childhood had recurrent stones. 17, 18 However, these studies did not account for differential followup, which would bias recurrence rates to appear lower than they really were. Other prior series that examined stone recurrence were likely not representative of the contemporary population of children with nephrolithiasis, included many patients with infectious stones or included only children who underwent surgery. In exploratory analyses we also found that completing 24-hour urine collections was associated with a decreased risk of recurrence. Although Figure 2 . Kidney stone recurrence-free survival of children and adolescents with incident nephrolithiasis. Risk of symptomatic kidney stone recurrence was approximately 50% at 3 years after index stone. kidney stone recurrences result in substantial morbidity and health care expenditures, little is known about practices that decrease stone recurrence for children and adolescents. Our results provide preliminary evidence regarding the effectiveness of 24-hour urine collections in decreasing stone recurrence. Completing at least one 24-hour urinalysis after an incident stone was associated with a 60% decrease in risk of recurrence. Excluding patients with comorbid disease did not substantively change the association between completion of 24-hour urinalysis and stone recurrence. Our analyses, which should be considered hypothesis generating due to the observational nature of this study, also demonstrated that completing a 24-hour urinalysis modified the effectiveness of PPT. PPT initiated after completion of a 24-hour urinalysis was associated with an 81% decrease in risk of kidney stone recurrence, whereas no association between empirical PPT and stone recurrence was detected. The association between completing a 24-hour urinalysis without prescription of PPT became significant after excluding patients with comorbid disease. This finding suggests that the benefit of assessing urine chemistries for healthy patients with idiopathic stones extends beyond targeting hypocitraturia and hypercalciuria with citrate therapy and thiazides, respectively.
There are multiple possible explanations for these results that should be explored in future studies. One possible explanation is that serial monitoring of 24-hour urine chemistries improves adherence to general recommendations to decrease stone recurrence. Patients who complete 24-hour urine collections may be more likely to be adherent to dietary recommendations and PPT. This hypothesis is supported by the observation that 24-hour urine volume increased on subsequent urinalysis. An alternative explanation is that assessing urine chemistries identifies specific metabolic abnormalities that could be treated with targeted therapy, such as lemonade or citrate for patients with hypocitraturia 21 and thiazides for patients with hypercalciuria.
22e26 However, in successful clinical trials of adult participants only 22% of those treated with citrate and 47% of those treated with thiazides met prespecified cut points for hypocitraturia and hypercalciuria, respectively. 23 Our study highlights the need for well designed randomized trials to test the efficacy of targeted PPT on stone recurrence in children and adolescents. Additionally studies that determine the optimal dosage and point to begin PPT for children with nephrolithiasis are needed.
A limitation of this study is that patients were not followed prospectively for stone recurrence. However, we defined stone occurrence by the presence of pain and/or vomiting combined with diagnostic imaging findings. These outcome measures were reliably documented and able to be identified from chart review. In addition, these results should be applied only to patients who share the characteristics of our study population. Recurrence rates are likely different for patients with monogenic causes of stones and disorders such as spina bifida. Furthermore, we may have underestimated recurrent stone formation because we did not classify asymptomatic stones diagnosed on surveillance imaging as a recurrence. Although patients generally underwent ultrasonography every 6 months, we chose to measure symptomatic recurrence because it is a clinically important outcome and it mitigates lead time bias for patients with more frequent followup and surveillance imaging.
There is also the possibility of unmeasured differences in adherence between groups. Patients who did not complete 24-hour urine collections may have been less likely to adhere to general risk reduction recommendations (eg decreased salt intake) and, thus, may have been at increased risk for recurrence. However, 24-hour urine collections were ordered for all patients in this study, thus limiting any confounding by indication introduced by perceived risk of recurrence. Additionally we adjusted for adherence to followup, which is an observable, although imperfect, measure of treatment adherence. Finally, the mean followup in this study was shorter than most randomized trials that assess the efficacy of PPT to decrease stone recurrence among adults. However, this study had sufficient power to detect differences in stone recurrence.
CONCLUSIONS
The probability of kidney stone recurrence is high during childhood, with approximately 50% of children and adolescents presenting with a symptomatic recurrence within 3 years of the first kidney stone. The usefulness of 24-hour urinalysis in decreasing kidney stone recurrence should be explored in prospective studies. 
EDITORIAL COMMENTS
Previous studies on pediatric nephrolithiasis may have underestimated recurrence, given that patients were lost to followup. The 50% probability of stone recurrence within 3 years reported in this series is likely more representative of the current state of pediatric stone disease. While the rapid increase in pediatric stone disease has been well established, this study highlights an additional burden of disease. Quoting this risk of stone recurrence to families may alone encourage strong adherence to preventive strategies. However, given the increasing incidence of pediatric nephrolithiasis coupled with a high recurrence rate of this disease, additional evaluation of prophylactic measures for pediatric stone disease should be encouraged. While undergoing 24-hour urine studies was associated with decreased risk of stone recurrence, the mechanism is unclear. Those completing urinary studies may be a motivated cohort, although the value of focused dietary counseling and targeted medical therapy should not be overlooked and warrants further investigation.
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